Compounds for targeted degradation of BRD9
US11691972B2 · kind B2 · utility
3Cited by
10References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2021 |
| Grant date | Jul 4, 2023 |
| Priority date | — |
| Expiry date | Dec 2, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A BRD9 protein degrading compound of structure or a pharmaceutically acceptable salt thereof is provided for the treatment of a disorder mediated by BRD9, including but not limited to abnormal cellular proliferation including cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.